Clostridium difficile Exocrine pancreatic Dysimmune insufficiency on hyperthyroidism compression Dysimmune meningitis Dysimmune enterocolitis obstruction by the tumor Ketoacidosis due to Carcinomatous peritonitis dysimmune diabetes Carcinomatous meningitis Nausea vomiting Dysimmune adrenal Intracranial hypertension insufficiency Hypercalcemia Dysimmune nephropathy Hyponatremia Dysimmune pancreatitis Dysimmune hepatitis Dysimmune hepatitis Dysimmune myocarditis Hepatic cancer progression (AST) Liver Enzymes Hepatic Sepsis Dysimmune myositis Elevation Concurrent medication (AST) Dysimmune hemolytic anemia (AST) Dysimmune hepatitis Intrinsic cancer Sclerosing cholangitis progression, gall, locoregional Jaundice, bilirubin Primary biliary cirrhosis tumor or extrinsic elevation Dysimmune compression GGT and ALP granulomatosis Sepsis elevation Dysimmune hemolytic Medication, parenteral anemia (unconjugated nutrition bilirubin) Dysimmune hemolytic chemotherapy toxicity anemia Tumor bleeding Dysimmune Marrow involvement hypothyroidism Deficiency Vitamin B9, B12 Dysimmune pancytopenia Hematologic Anemia or martial Immune thrombocytopenic inflammatory anemia purpura false anemia: hemodilution, Thrombotic splenomegaly, monoclonal microangiopathy: TTP, peak HUS Evans syndrome Immune thrombocytopenic Marrow involvement purpura (ITP) chemotherapy toxicity syndrome Disseminated intravascular Autoimmune pancytopenia coagulation due to tumor Thrombocytopenia Thrombotic progression microangiopathy: Myelodysplasia Thrombotic Heparin-induced thrombocytopenic purpura thrombocytopenia (TTP)
Clostridium difficile Exocrine pancreatic insufficiency on compression Dysimmune hyperthyroidism Nausea vomiting obstruction by the tumor Carcinomatous peritonitis Carcinomatous meningitis Intracranial hypertension Hypercalcemia Hyponatremia Dysimmune meningitis Dysimmune enterocolitis Ketoacidosis due to dysimmune diabetes Dysimmune adrenal insufficiency Dysimmune nephropathy Dysimmune pancreatitis Dysimmune hepatitis Hepatic Liver Enzymes Elevation Hepatic cancer progression Sepsis Concurrent medication Dysimmune hepatitis Dysimmune myocarditis (AST) Dysimmune myositis (AST) Dysimmune hemolytic anemia (AST) Jaundice, bilirubin elevation GGT and ALP elevation Intrinsic cancer progression, gall, locoregional tumor or extrinsic compression Sepsis Medication, parenteral nutrition Dysimmune hepatitis Sclerosing cholangitis Primary biliary cirrhosis Dysimmune granulomatosis Dysimmune hemolytic anemia (unconjugated bilirubin) Hematologic Anemia chemotherapy toxicity Tumor bleeding Marrow involvement Deficiency Vitamin B9, B12 or martial inflammatory anemia false anemia: hemodilution, splenomegaly, monoclonal peak Dysimmune hemolytic anemia Dysimmune hypothyroidism Dysimmune pancytopenia Immune thrombocytopenic purpura Thrombotic microangiopathy: TTP, HUS Evans syndrome Thrombocytopenia Marrow involvement chemotherapy toxicity Disseminated intravascular coagulation due to tumor progression Myelodysplasia Heparin-induced thrombocytopenia Immune thrombocytopenic purpura (ITP) syndrome Autoimmune pancytopenia Thrombotic microangiopathy: Thrombotic thrombocytopenic purpura (TTP)
Immuuntherapie%20met%20anti-PD%20en%20de%20bijwekrkngen.docx